MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Mcleod syndrome: Systematic review with meta-analysis

    A. Rochel Pérez, O. Cuevas Koh, K. Santos Zaldivar, R. Leal Ortega, R. Janssen-Aguilar, N. Mendez Dominguez (Mérida, Mexico)

    Objective: Analyze, review and describe the pathognomonic or characteristic signs and symptoms of Mcleod syndrome. Background: Mcleod syndrome is caused due to a mutation of…
  • MDS Virtual Congress 2020

    Sensory Trick in Oromandibular and Tongue Dystonia in Patient with Wilson’s Disease

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the case report is to demonstrate an unusual clinical feature of secondary dystonia. Background: A sensory trick (ST) is a voluntarily…
  • MDS Virtual Congress 2020

    Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome

    S. Weber, M. Zech, S. Boesch, J. Winkelmann (Kassel, Germany)

    Objective: To enrich the limited clinical and genetic data of an extremely rare recessive ataxia subtype. Background: Advances in NGS techniques led to an increase…
  • MDS Virtual Congress 2020

    Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

    T. Wirth, LL. Mariani, G. Bergant, M. Baulac, M.O Habert, N. Drouot, E. Ollivier, A. Hodžic, G.o Rudolf, P. Nitschke, G.a Rudolf, J. Chelly, C. Tranchant, M. Anheim, E. Roze (London, United Kingdom)

    Objective: To report two patients with early-onset dystonia-parkinsonism as a result of loss-of-function mutations in nuclear receptor subfamily 4 group A member 2 (NR4A2). Background:…
  • MDS Virtual Congress 2020

    PNPLA6-related Disorder With Expanded Phenotype Including Parkinsonism, Dystonia, And Abnormal Dopamine Transporter Imaging

    J. Witt, M. Davis (Seattle, WA, USA)

    Objective: To present a case of PNPLA6-related disorder with an expanded phenotype. Background: PNPLA6-related are autosomal recessive disorders with heterogeneous clusters of cerebellar ataxia, upper…
  • MDS Virtual Congress 2020

    Psychosocial Adjustment to Illness Scale in family carers of patients with Parkinson’s disease: Spanish validation

    L. Ambrosio, M.C Portillo, R. Martin-Lanas, M.V Navarta-Sanchez, M. Riverol (Pamplona, Spain)

    Objective: To analyse the psychometric properties of the Spanish version of the Psychosocial Adjustment to Illness Scale (PAIS) in family carers of patients with Parkinson’s…
  • MDS Virtual Congress 2020

    Long-term course and confounding factors of MDS-UPDRS in a longitudinal single-center (DeNoPa) and a multicenter cohort (PPMI)

    M. Bartl, M. Dakna, S. Schade, E. Lang, C. Trenkwalder, B. Mollenhauer (Göttingen, Germany)

    Objective: To systematically compare long-term course of Parkinson's disease (PD) by the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and investigate possible predictive parameters of different…
  • MDS Virtual Congress 2020

    Quantitative extremity movement measurement

    J. Brasic, T. Harrigan, B. Hwang, K. Mills, A. Pantelyat, J. Bang, A. Syed, P. Vyas, S. Martin, A. Jamal, R. Panaparambil, A. Gaite, L. Ziegelman, M. Hernandez (Baltimore, MD, USA)

    Objective: To demonstrate the feasibility of a simple low-cost procedure to quantitatively measure movements in the extremities of people with Parkinson's disease and other movement…
  • MDS Virtual Congress 2020

    Cognitive pretesting of the Functional Rating Scale 2.0 for Huntington’s disease (FuRST 2.0): An iterative process

    P. Feigenbaum, R. Fuller, N. Lapelle, C. Fitzer-Attas, S. Luo, B. Tilley, M. Guttman, C. Goetz, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Develop a functional rating scale for Huntington’s disease (HD) using iterative rounds of cognitive pretesting (CPT). Background: We previously reported on focus group and…
  • MDS Virtual Congress 2020

    Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results

    J. Gallagher, J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the change over time (1-2 years) on the Clinical Dementia Rating Sum of Boxes (CDR-SOB) in Parkinson's disease (PD). Background: The CDR-SOB…
  • « Previous Page
  • 1
  • …
  • 1161
  • 1162
  • 1163
  • 1164
  • 1165
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley